Shandong Bailong Chuangyuan Bio-Tech (SHA:605016) plans to issue convertible bonds worth up to 748.1 million yuan, according to Shanghai bourse filing on Friday.
Proceeds from the issuance will be used for the construction of a new food raw material plant in Thailand and the expansion of a sugar production plant that will produce 22,000 tons per year.
The Chinese prebiotics and dietary fibers manufacturer's shares fell 2% at the close.
UBS Group (UBSG.SW) on Thursday priced concurrent and separate offers to redeem nine series of Credit Suisse Group-issued outstanding senior notes.The offers cover 750 million pounds sterling of 7.375% notes due Sept. 7, 2033; $697.1 million of 6.442% notes due Aug. 11, 2028; and $2.25 billion of 4.282% notes due Jan. 9, 2028. The offers also include up to $4 billion of six other series of outstanding notes maturing in 2029, 2031 and 2033.The Swiss banking group will close the offer on Thursday afternoon, with settlement expected by Sept. 14.
Paradigm Biopharmaceuticals (ASX:PAR) drew down the remaining balance of tranche 4, valued at $2 million, under its $27 million convertible note facility with Obsidian Global Partners, according to a Friday Australian bourse filing.Following the drawdown, about $5 million remains available under the facility, providing continued financial flexibility to support phase 3 execution and broader commercial readiness activities, the filing added.The company's shares plunged 13% in recent Friday trade.
Bank of Chongqing (HKG:1963, SHA:601963) issued 5 billion yuan of three-year fixed-rate green bonds, according to a Friday filing with the Shanghai bourse.The bonds have a coupon rate of 1.59%. Proceeds will go to green projects, the filing said.